Baseline characteristics of study participants
| (n=51) | |
| Age, years, mean±SD | 42±11 |
| Female gender, n (%) | 33 (65) |
| Race/ethnicity | |
| White, n (%) | 36 (70) |
| African American, n (%) | 1 (2) |
| Asian/Pacific Islander, n (%) | 7 (14) |
| Other, n (%) | 7 (14) |
| Bachelor’s degree or higher, n (%) | 44 (86) |
| Active inhaled tobacco/drug use, n (%) | 7 (14) |
| Medical history | |
| Hypertension, n (%) | 5 (10) |
| Diabetes, n (%) | 2 (4) |
| HIV, n (%) | 2 (4) |
| COVID-19 history | |
| Any symptom*, n (%) | 51 (100) |
| Symptom severity† | |
| Mild | 7 (14) |
| Moderate | 19 (37) |
| Severe | 25 (49) |
| Hospitalisation, n (%) | 4 (8) |
| ICU treatment, n (%) | 1 (2) |
| Mechanical ventilation, n (%) | 0 |
*Cough, pharyngitis, fever, dyspnoea and/or anosmia.
†Mild=no limitation, moderate=slight limitation and severe=significant limitation in daily activities.
ICU, intensive care unit.